In the most recent WHO classification of brain tumours, the presence of IDH1 mutations is used as a diagnostic marker within glioma (such as astrocytoma, IDH mutant and GB, IDH mutant) [47]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).